Abstract
(N Engl J Med. 2022;387:2085–2086) Opioid use during pregnancy continues to rise and result in adverse maternal and neonatal outcomes. Buprenorphine and methadone are medications used for opioid use disorder (OUD) treatment to help prevent risks such as overdose and preterm birth. While methadone was used for decades to treat perinatal OUD, it suffers from several issues. The primary issue is that it can only be given by federally licensed drug and alcohol treatment programs, which can be a barrier for many women requiring treatment. Another issue is that it is a long-acting drug.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
